KR950700314A - 루이스형 당쇄 유도체(Lewis-type sugar chain derivative) - Google Patents
루이스형 당쇄 유도체(Lewis-type sugar chain derivative)Info
- Publication number
- KR950700314A KR950700314A KR1019940702604A KR19940702604A KR950700314A KR 950700314 A KR950700314 A KR 950700314A KR 1019940702604 A KR1019940702604 A KR 1019940702604A KR 19940702604 A KR19940702604 A KR 19940702604A KR 950700314 A KR950700314 A KR 950700314A
- Authority
- KR
- South Korea
- Prior art keywords
- lewis
- sugar chain
- following formula
- chain derivative
- derivatives represented
- Prior art date
Links
- -1 acetamino group Chemical group 0.000 claims abstract 2
- 125000003342 alkenyl group Chemical group 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims abstract 2
- 125000000304 alkynyl group Chemical group 0.000 claims abstract 2
- 125000002446 fucosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)* 0.000 claims abstract 2
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 2
- 239000001257 hydrogen Substances 0.000 claims abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 2
- 230000004054 inflammatory process Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000003800 Selectins Human genes 0.000 abstract 1
- 108090000184 Selectins Proteins 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000021164 cell adhesion Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명의 목적은 의약으로서 유용하며, 또한 모라놀린을 함유하는 하기 일반식(Ⅰ)로 표시되는 신규한 SLe형 당쇄 유도체를 제공하기 위한 것이다.
상기 식에서, R1은 수소, 저급 알킬, 저급 알케닐 또는 저급 알키닐을 나타내며, R2및 R2는 각각 서로 다르며, 갈락토실, 시알릴갈락토실 또는 푸코실기를 나타내며, R4는 히드록시 또는 아세트아미노기를 나타낸다.
본 발명은 모라놀린을 함유하는 신규한 구조를 갖는 당쇄 유도체로 구성된다. 본 화합물은 세포 접착 저해 활성을 갖고 있어서, 셀렉틴을 길항적으로 저해시킴으로써 염증이나 염증을 수반하는 혈전 형성, 천식, 류마티즘의 치료, 면역질환 및 암의 예방, 치료등에 유용하다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 하기 일반식(Ⅰ)로 표시되는 루이스형 당쇄 유도체 :상기 식에서, R1은 수소, 저급 알킬, 저급 알케닐 또는 저급 알키닐을 나타내며, R2및 R3는 각각 서로 다르며, 갈락토실, 시알릴갈락토실 또는 푸코실기를 나타내며, R4는 히드록시 또는 아세트아미노기를 나타낸다.
- 하기 식으로 표시되는 루이스 X 유도체 :
- 하기 식으로 표시되는 루이스 X 유도체 :
- 하기 식으로 표시되는 루이스 X 유도체 :
- 하기 식으로 표시되는 루이스 A 유도체 :
- 하기 식으로 표시되는 루이스 A 유도체 :
- 하기 식으로 표시되는 루이스 A 유도체 :
- 하기 식으로 표시되는 루이스 A 유도체 :※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP92-46081 | 1992-01-31 | ||
JP4608192 | 1992-01-31 | ||
JP92-93431 | 1992-03-18 | ||
JP9343192 | 1992-03-18 | ||
JP92-273615 | 1992-09-16 | ||
JP27361592 | 1992-09-16 | ||
PCT/JP1993/000106 WO1993015098A1 (en) | 1992-01-31 | 1993-01-29 | Lewis-type sugar chain derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950700314A true KR950700314A (ko) | 1995-01-16 |
Family
ID=27292504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019940702604A KR950700314A (ko) | 1992-01-31 | 1993-01-29 | 루이스형 당쇄 유도체(Lewis-type sugar chain derivative) |
Country Status (5)
Country | Link |
---|---|
US (1) | US5498604A (ko) |
EP (1) | EP0627442A4 (ko) |
KR (1) | KR950700314A (ko) |
CA (1) | CA2129140A1 (ko) |
WO (1) | WO1993015098A1 (ko) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750508A (en) * | 1993-06-16 | 1998-05-12 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5679321A (en) * | 1993-06-17 | 1997-10-21 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
WO1995006057A1 (fr) * | 1993-08-23 | 1995-03-02 | Nippon Shinyaku Co., Ltd. | Derive de galactosylmoraniline |
JPH07126278A (ja) * | 1993-09-10 | 1995-05-16 | Daikin Ind Ltd | フッ素化ガングリオシドgm3 |
WO1995013068A1 (fr) * | 1993-11-12 | 1995-05-18 | Nippon Shinyaku Co., Ltd. | Composition medicamenteuse pour la circulation |
DE4408248A1 (de) * | 1994-03-11 | 1995-09-14 | Hoechst Ag | Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung |
WO1995026969A1 (fr) * | 1994-03-31 | 1995-10-12 | Nippon Shinyaku Co., Ltd. | Derive de moranoline |
US5700918A (en) * | 1994-04-01 | 1997-12-23 | Nippon Shinyaku Co., Ltd. | Moranoline derivative |
JPH08109134A (ja) * | 1994-10-11 | 1996-04-30 | Sanwa Kagaku Kenkyusho Co Ltd | 細胞変成抑制並びに臓器毒性軽減剤 |
WO1997000881A1 (en) * | 1995-06-22 | 1997-01-09 | Nippon Shinyaku Co., Ltd. | Moranoline derivatives |
BR9608873A (pt) * | 1995-06-29 | 1999-07-06 | Texas Biotechnology Corp | Inibidores de selectina de moléculas pequenas di e trivalentes |
WO1997002278A1 (fr) * | 1995-06-30 | 1997-01-23 | Nippon Shinyaku Co., Ltd. | Derives formant une chaine saccharidique et procede pour les produire |
CZ89098A3 (cs) * | 1995-09-29 | 1998-09-16 | Glycim Oy | Syntetické polylaktosaminy obsahující až multivalentní sLEX a metody pro jejich použití |
WO1998024453A1 (fr) * | 1996-12-05 | 1998-06-11 | Nippon Shinyaku Co., Ltd. | Medicaments pour la myelopathie |
WO1998036757A1 (en) * | 1997-02-21 | 1998-08-27 | Nippon Shinyaku Co., Ltd. | Remedy for peptic ulcer |
JPH10251152A (ja) * | 1997-03-14 | 1998-09-22 | Nippon Shinyaku Co Ltd | 虚血再灌流障害治療剤 |
US6191271B1 (en) | 1997-09-05 | 2001-02-20 | Glycim Oy | Synthetic divalent sLex containing polylactosamines and methods for use |
US7292232B2 (en) * | 2004-04-30 | 2007-11-06 | Microsoft Corporation | Data input devices and methods for detecting movement of a tracking surface by a laser speckle pattern |
CN108299525B (zh) * | 2018-01-05 | 2021-03-26 | 佛山科学技术学院 | 路易斯寡糖-x的合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2064527B (en) * | 1979-12-08 | 1984-05-02 | Nippon Shinyaku Co Ltd | Moranoline derivatives and process for preparation thereof |
GB2181729B (en) * | 1985-10-12 | 1990-04-04 | Nippon Shinyaku Co Ltd | Glucosylmoranoline derivatives and production thereof |
JPS62174095A (ja) * | 1985-10-12 | 1987-07-30 | Nippon Shinyaku Co Ltd | グルコシルモラノリン誘導体 |
JPS62242692A (ja) * | 1986-04-15 | 1987-10-23 | Nippon Shinyaku Co Ltd | モラノリン誘導体の製造法 |
-
1993
- 1993-01-29 CA CA002129140A patent/CA2129140A1/en not_active Abandoned
- 1993-01-29 WO PCT/JP1993/000106 patent/WO1993015098A1/ja not_active Application Discontinuation
- 1993-01-29 US US08/256,991 patent/US5498604A/en not_active Expired - Fee Related
- 1993-01-29 EP EP93902546A patent/EP0627442A4/en not_active Withdrawn
- 1993-01-29 KR KR1019940702604A patent/KR950700314A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2129140A1 (en) | 1993-08-05 |
EP0627442A1 (en) | 1994-12-07 |
WO1993015098A1 (en) | 1993-08-05 |
EP0627442A4 (en) | 1995-01-11 |
US5498604A (en) | 1996-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950700314A (ko) | 루이스형 당쇄 유도체(Lewis-type sugar chain derivative) | |
MX9202630A (es) | Derivados de sulfamato anticonvulsivos. | |
AR030816A1 (es) | Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos | |
FR2416012A1 (fr) | Derives de l'imidazole et medicament contenant ces substances | |
DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
KR950701640A (ko) | 에리트로마이신 유도체(eryhromycin derivative) | |
IT7828053A0 (it) | Composizioni biocide liquide stabili per la protezione di ambienti acquosi contro infezioni da microorganismi | |
EP1362846A4 (en) | AMINOETHANOLDERIVATE | |
GEP19971265B (en) | Substituted sulphonamides,, the substituted cyclic amines in the form of intermediate compounds for reception of the substituted sulphonamides and the pharmaceutical composition on the basis of the substituted sulphonamides displaying activity towards thromboxane receptors | |
KR930703303A (ko) | 1, 4-벤조티아제핀 유도체 | |
KR890003382A (ko) | 항 비루스성 화합물 | |
CA2238875A1 (en) | Tri-aryl ethane derivatives as pde iv inhibitors | |
PT81855B (pt) | Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem | |
FR2363330A1 (fr) | Medicament destine a reduire la fertilite chez les mammiferes | |
KR910004191A (ko) | 신질환치료제 | |
ATE13423T1 (de) | Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen. | |
YU37597A (en) | New pyranosid derivatives | |
ES2172294T3 (es) | Nuevos derivados del 1-indanol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
GB1274809A (en) | Evomonoside derivatives | |
FI875729A0 (fi) | Cytostatiska platinafoereningar. | |
FR2452929A1 (fr) | Compositions pharmaceutiques synergiques protegeant contre les rayonnements | |
FR2385756A1 (fr) | Composes polyhydroxyles contenant des groupes acyluree | |
ES2194320T3 (es) | Sustancias naturales antivirales o antitumorales y uso de las mismas. | |
KR970064604A (ko) | 벤조피란 유도체 및 그의 심장질환 치료제로서의 용도 | |
DK1107751T3 (da) | Lægemiddel indeholdende platinkompleksforbindelser samt anvendelse deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |